158 related articles for article (PubMed ID: 10456630)
21. An association between anxiety and neurocardiogenic syncope during head-up tilt table testing.
Cohen TJ; Thayapran N; Ibrahim B; Quan C; Quan W; von zur Muhlen F
Pacing Clin Electrophysiol; 2000 May; 23(5):837-41. PubMed ID: 10833703
[TBL] [Abstract][Full Text] [Related]
22. Predictors of tilting test negativization during beta-blocker treatment in patients with neurocardiogenic syncope.
Vincenti A; Schena F; Cirò A; De Ceglia S
Cardiologia; 1999 May; 44(5):461-8. PubMed ID: 10389353
[TBL] [Abstract][Full Text] [Related]
23. Head-up tilt test in patients with high pretest likelihood of neurally mediated syncope: an approximation to the "real sensitivity" of this testing.
Pérez-Paredes M; Picó-Aracil F; Florenciano R; Sánchez-Villanueva JG; Ruiz Ros JA; Ruipérez JA
Pacing Clin Electrophysiol; 1999 Aug; 22(8):1173-8. PubMed ID: 10461293
[TBL] [Abstract][Full Text] [Related]
24. Plasma galanin response to head-up tilt in normal subjects and patients with recurrent vasovagal syncope.
Bondanelli M; Alboni P; Margutti A; Franceschetti P; Dinelli M; Gruppillo P; Marchi P; degli Uberti EC
Metabolism; 2003 Mar; 52(3):315-21. PubMed ID: 12647269
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of pindolol in neurocardiogenic syncope.
Iskos D; Dutton J; Scheinman MM; Lurie KG
Am J Cardiol; 1998 Nov; 82(9):1121-4, A9. PubMed ID: 9817494
[TBL] [Abstract][Full Text] [Related]
26. The usefulness of tilt testing with an intravenous beta-blocker in assessing the efficacy of long-term therapy in patients with vasovagal syncope.
Gielerak G; Makowski K; Dłuzniewska E; Stec A; Cholewa M
Kardiol Pol; 2003 Aug; 59(8):93-104; commentary 103-4. PubMed ID: 14560324
[TBL] [Abstract][Full Text] [Related]
27. Distinct hemodynamic profiles in patients with vasovagal syncope: a heterogeneous population.
Shen WK; Low PA; Rea RF; Lohse CM; Hodge DO; Hammill SC
J Am Coll Cardiol; 2000 May; 35(6):1470-7. PubMed ID: 10807449
[TBL] [Abstract][Full Text] [Related]
28. [Analysis of heart rate variability during the head-up tilt test in patients with vasovagal syncope].
Mitro P; Rybár R
Vnitr Lek; 2002 Apr; 48(4):314-9. PubMed ID: 12061181
[TBL] [Abstract][Full Text] [Related]
29. Long-term effects of pharmacological therapy for vasovagal syncope on the basis of reproducibility during head-up tilt testing.
Nakagawa H; Kobayashi Y; Kikushima S; Shinohara M; Obara C; Zinbo Y; Chiyoda K; Miyata A; Tanno K; Baba T; Katagiri T
Jpn Circ J; 1998 Oct; 62(10):727-32. PubMed ID: 9805252
[TBL] [Abstract][Full Text] [Related]
30. Transient modification of baroreceptor response during tilt-induced vasovagal syncope.
Samniah N; Sakaguchi S; Ermis C; Lurie KG; Benditt DG
Europace; 2004 Jan; 6(1):48-54. PubMed ID: 14697726
[TBL] [Abstract][Full Text] [Related]
31. Role of the peripheral serotoninergic system in the pathogenesis of vasovagal syncope.
Mitro P; Hijova E; Mudrakova K
Bratisl Lek Listy; 2006; 107(6-7):248-52. PubMed ID: 17051902
[TBL] [Abstract][Full Text] [Related]
32. Prospective evaluation of high-dose or low-dose isoproterenol upright tilt protocol for unexplained syncope in young adults.
Carlioz R; Graux P; Haye J; Letourneau T; Guyomar Y; Hubert E; Bodart JC; Lequeuche B; Burlaton JP
Am Heart J; 1997 Mar; 133(3):346-52. PubMed ID: 9060805
[TBL] [Abstract][Full Text] [Related]
33. Esmolol tilt testing with esmolol withdrawal for the evaluation of syncope in the young.
Ovadia M; Thoele D
Circulation; 1994 Jan; 89(1):228-35. PubMed ID: 7904232
[TBL] [Abstract][Full Text] [Related]
34. Head-up tilt test with clomipramine challenge in vasovagal syndrome--a new tilt testing protocol.
Theodorakis GN; Livanis EG; Leftheriotis D; Flevari P; Markianos M; Kremastinos DT
Eur Heart J; 2003 Apr; 24(7):658-63. PubMed ID: 12657224
[TBL] [Abstract][Full Text] [Related]
35. Nitrate-potentiated head-up tilt testing (HUT) has a low diagnostic yield in patients with likely vasovagal syncope.
Petix NR; Del Rosso A; Furlan R; Guarnaccia V; Zipoli A
Pacing Clin Electrophysiol; 2014 Feb; 37(2):164-72. PubMed ID: 23992559
[TBL] [Abstract][Full Text] [Related]
36. Role of endogenous opioids in syncope induced by head-up tilt test and its relationship with isoproterenol-dependent and isoproterenol-independent neurally-mediated syncope.
Pérez-Paredes M; Picó-Aracil F; Fuentes-Jiménez T; Sánchez-Villanueva JG; Expósito-Ordoñez E; Gonzálvez-Ortega M; González-Caballero E; Nicolás-Garcia F; Nuño de la Rosa JA; Ruiz-Ros JA; Ruipérez-Abizanda JA
Int J Cardiol; 1998 Dec; 67(3):211-8. PubMed ID: 9894701
[TBL] [Abstract][Full Text] [Related]
37. Dynamic changes of P-wave duration and P-wave axis during head-up tilt test in patients with vasovagal syncope.
Mitro P; Spegár J
Pacing Clin Electrophysiol; 2006 Jul; 29(7):742-6. PubMed ID: 16884510
[TBL] [Abstract][Full Text] [Related]
38. False positive responses to head-up tilt testing in elderly patients with paroxysmal atrial fibrillation.
Oliveira MM; Feliciano J; Timóteo AT; da Silva N; Antunes E; Silva S; Alves S; Silva-Carvalho L; Ferreira R
Rev Port Cardiol; 2008 Nov; 27(11):1383-94. PubMed ID: 19227806
[TBL] [Abstract][Full Text] [Related]
39. The effects of intrinsic sympathomimetic activity on beta-blocker efficacy for treatment of neurocardiogenic syncope.
Cohen TJ; Cayenne S; Black M; Doolittle S; Ibrahim B; Quan W
J Invasive Cardiol; 1999 Jul; 11(7):457-60. PubMed ID: 10745573
[TBL] [Abstract][Full Text] [Related]
40. Value of symptoms to predict tilt testing outcome in patients with clinical suspicion of vasovagal syncope.
Vallejo M; Hermosillo AG; Márquez MF; Urquidez AK; Sotomayor A; Salas E; Cárdenas M
Arch Med Res; 2007 Jul; 38(5):579-83. PubMed ID: 17560466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
